Neerja Agrawal, Swati Hiwale


Background:Hyperglycaemia in diabetic condition is metabolic dysfunction which can lead to increased free radical production causing oxidative damage and stress. The present study aims to evaluate malondialdehyde (MDA), ischemia modified albumin (IMA) concentrations in diabetics, as a marker of oxidative stress. Methodology: A total of 60 diabetic subjects with 45 age, sex matched healthy controls. MDA and IMA were assessed from serum using standardised method and were compared amongst diabetic subjects and control subjects. Results: Two groups were found to be matched for general characteristics. The concentration of MDA and IMA was found to be increased significantly in diabetics compared to normal controls. Further MDA and IMA were also found to be significantly higher in male diabetic subjects compared to female diabetic subjects when differences in non diabetic male and female subjects failed to reach statistical significance. Conclusion: Diabetic subjects show high levels of MDA and IMA those can be result of oxidative stress of the hyperglycaemic state.


diabetes mellitus, malondialdehyde (MDA), ischemia modi

Full Text:



American Diabetes Association (2010) Diabetes Care, 33: S62-S68.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus2, Follow up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26: 3160-3167.

Ramachandran A, Das AK, Joshi SR, Yajnik CS, Shah S, Kumar KMP. Current status of diabetes in India and need for novel therapeutic agents. J Assoc Physc India 2010;58: 7-9.

Halliwell B, Gutteridge J Free Radicals in Biology and Medicine. Oxford University Press, New York, NY, USA. 2007.

Yoshikawa T. Science of free radicals. Koudan Sha Saientifikku, Tokyo. 1997.

Wang X, Martindale JL, Liu Y, Holbrook, NJ. The cellular response to oxidative stress: influences of mitogen activated protein kinase signalling pathways on cell survival. Biochem J 1998; 333: 291-300.

Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Fernyhough P et al., A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001; 15: 2508-2514.

Styskal J, Remmen H van, Richardson A, Salmon AB. Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radical Bio Med 2012; 52: 46-58.

Yoshikawa T. A Guide to Free Radicals. Part 2. Sentan Igaku Sha, Tokyo, 1998. J Japan Med Assoc, 124:1549-1553.

Cynamon H, Isenberg N, Nguyen C. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. Clin Chim Acta 1985; 151:169-176.

Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of ischemia modified albumin, a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. J Emerg Med 2004; 21: 29-34.

Jaganjac M, Tirosh O, Cohen G, Sasson S, Zarkovic N. Reactive aldehydes second messengers of free radicals in diabetes mellitus. Free Radical Res 2013; 47: 39-48.

Shodehinde SA, G Oboh. (2013) Antioxidant properties of aqueous extracts of unripe Musa paradisiaca on sodium nitroprus- side induced lipid peroxidation in rat pancreas in vitro. Asian Pac J Trop Biomed 2013; 3:449–457.

Bandeira SM, Guedes GS, daFonseca LJS, Pires AS, Gelain DP, JC Moreira. 2012 Characterization of blood oxidative stress in type2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med and Cell Longev 2012; 1-13.

Saddala RR, Thopireddy L, Ganapathi N, Kesireddy SR. Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous root. Exp Toxicol Pathol 2013; 65: 15-19.

Catanzaroa O, Capponia JA, Michielia J, Labala, Martinoa ID, Sirois P. Bradykinin B1 antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system, Peptides 2013; 44: 100-104.

Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, et al., A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 2013; 36:425-432.

Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. The relationship between diabetic retinopathy and serum levels of ischemiamodified albumin and malondialdehyde. Retina 2011; 31:602–608.

Lodovicia M, Giovannellia L, Pitozzia V, Bigaglia E, Bardinib G, Rotellab CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 2008; 638:98-102.


  • There are currently no refbacks.